Jorge Carrizosa

Dr. Jorge Carrizosa

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Neurocritical Care
Verified
Journal Article
Closed access
PDF file
DGDaniel Godoy
Daniel Godoy
JCJorge Carrizosa
Jorge Carrizosa
SASergio Aguilera-Albesa
Sergio Aguilera-Albesa
WVWalter Videtta
Walter Videtta
MJManuel Jibaja
Manuel Jibaja
LMLatin America Brain Injury Consortium (LABIC) Members
Latin America Brain Injury Consortium (LABIC) Members

1 February 2026 in Neurology Clinical Practice
Verified
Journal Article
Closed access
ASAayesha J. Soni
Aayesha J. Soni
RCR. Grace Couper
R. Grace Couper
MGManqoba Gule
Manqoba Gule
JPJohn Angelo Luigi Santiago Perez
John Angelo Luigi Santiago Perez
BABelal Aldabbour
Belal Aldabbour
JBJorge G. Burneo
Jorge G. Burneo
Status epilepticus (SE) is a neurologic emergency with disproportionate mortality and morbidity in low- and middle-income countries. Existing SE guidelines are largely based on high-income country contexts, limiting applicability in settings with diagnostic, therapeutic, and infrastructural constraints. We aimed to examine expert clinician perspectives on SE management across recourse-limited settings to identify common barriers and context-specific strategies. This study used a convergent parallel mixed methods approach, interconnecting quantitative and qualitative data collected from an online survey. Experts in SE management were purposively sampled to balance clinical expertise across 3 physician disciplines (neurology, emergency medicine, and critical care) and geographic locations. Invitations to participate were sent to 48 experts from 22 different countries. Qualitative data using thematic analysis and descriptive statistics for quantitative analysis was used. We received responses from 28 clinical experts, spanning 15 countries across 4 continents. Over 96% (27/28) agreed on the importance of guidelines or relevant subsections applicable to resource-limited settings. Experts highlighted inadequate SE education at multiple levels, but less than half (12/28) reported discussing SE management during routine clinic visits. A common theme was a lack of access to anti-seizure medications (ASMs), with 86% (24/28) agreeing that oral ASMs should be included in SE guidelines, although there was no consensus on what these should be. Only 39% (11/28) of experts had consistent access to electroencephalography (EEG), and there was little agreement about the duration and frequency of serial intermittent EEGs in the absence of continuous EEG. Nearly all experts (27/28) agreed that multicenter international efforts are essential to understand current practices and to improve patient outcomes. Other proposed solutions included implementing locally adapted practices to improve care, such as remote tele-monitoring and improving SE education and training. This study provides the most geographically diverse expert insight to date on SE care in recourse-limited settings, underscoring systemic barriers that transcend clinical decision-making. Inclusive, context-sensitive frameworks and implementation strategies are urgently needed. Our findings provide expert-informed priorities to guide future policy, research, and clinical practice for equitable SE care.

19 April 2021 in Revista de la Facultad de Medicina
Verified
Journal Article
Open access
PDF file
JCJorge Alberto Cortes
Jorge Alberto Cortes
SMSonia Isabel Cuervo Maldonado
Sonia Isabel Cuervo Maldonado
LBLaura Cristina Nocua Baez
Laura Cristina Nocua Baez
MRMartha Carolina Valderrama Rios
Martha Carolina Valderrama Rios
ESEdgar Alberto Sánchez
Edgar Alberto Sánchez
NGNathaly González
Nathaly González
La neumonía sigue siendo una de las principales causas de consulta y de hospitalización a la que, además de su un alto impacto en términos de morbilidad y mortalidad, se suma la actual problemática de resistencia a los antimicrobianos, por lo que establecer directrices que permitan su adecuado diagnóstico y tratamiento es de gran importancia para obtener mejores desenlaces clínicos y promover un uso racional de antibióticos en estos pacientes. La presente guía de práctica clínica (GPC) contiene recomendaciones basadas en la evidencia para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad en adultos, las cuales fueron realizadas mediante el proceso de adaptación de GPC basadas en la evidencia para el contexto colombiano.

19 November 2022 in The Ultrasound Journal
Verified
Journal Article
Open access
PDF file
Edith Elianna Rodriguez AparicioEdith Elianna Rodriguez Aparicio
Edith Elianna Rodriguez Aparicio
JCJorge Carrizosa
Jorge Carrizosa
DLDavid Rene Rodriguez Lima
David Rene Rodriguez Lima
Background: Increases in the diameter of the optic nerve sheath (ONSD) on ultrasound are associated with high intracranial pressure (hICP). The normal value varies with altitude and the population studied. The objective of this study is to describe the normal values of the ONSD in a healthy adult population of the city of Bogotá, Colombia, at 2640 meters above sea level (masl). Patients and methods: A prospective observational study was conducted on a total of 247 healthy individuals recruited from May 2021 to May 2022 who were subjected to the color, low power, optic disk, safety, elevated frequency, dual (CLOSED) protocol for measuring the bilateral ONSD adjusted to the eyeball transverse diameter (ETD). Results: A total of 230 individuals were analyzed; the average ONSD of the right eye (RE) was 0.449 cm (range 0.288–0.7) and that of the left eye (LE) was 0.454 cm (range 0.285–0.698); the correlation between RE and LE was 0.93 ( p < 0.005), and the correlation of the ONSD/ETD ratios for the RE and LE was lower ( r 2 = 0.79, p < 0.005). A total of 10.8% of the studied population had values greater than 0.55 cm. Conclusions: The median ONSD and ONSD/ETD ratio in the city of Bogotá are similar to those described in other populations; however, approximately 10.8% of the healthy population may present higher values, which would limit the use of ONSD on its own for clinical decision-making, only repeated measurements with significant changes in the ONSD and ONSD/ETD or asymmetries between the measurements of both eyes linked to clinical findings would allow the diagnosis of hICP.

29 May 2024 in medRxiv
Verified
Preprint
Open access
PDF file
JIJuan David Villalobos Ibarra
Juan David Villalobos Ibarra
JCJorge Carrizosa
Jorge Carrizosa
AVAndrea Vargas
Andrea Vargas
CMCarlos Martinez
Carlos Martinez
DBDenise Battaglini
Denise Battaglini
DGDaniel Agustin Godoy
Daniel Agustin Godoy
Introduction: The incidence of stroke mimic symptoms is around 30%. These symptoms impact healthcare costs, often leading mimic stroke patients to undergo unnecessary clinical tests, imaging, and treatments. Objectives: The main goal of this study is to describe the types of stroke mimic symptoms and estimate healthcare costs in patients with stroke mimics. Secondary objectives include comparing costs based on Telestroke Mimics Stroke and FABS scores and determining the frequency of thrombolysis. Methods: We conducted a retrospective observational study. We reviewed medical records of all patients admitted to Fundación Santa Fe de Bogotá with a final diagnosis of ischemic stroke mimic. We characterized the study population and analyzed the costs of interventions in these patients. Results: A total of 111 patients were included. The average age at mimic presentation was 65 ± 19.4 years, with transient ischemic attack (TIA) being the most common cause of mimics in both sexes, followed by migraine. Tissue plasminogen activator was administered in 0.9% of patients. The direct costs of activating the stroke code averaged US$1,098.72, with a cost of laboratory and imaging at US$773.95. The average cost of total hospitalization was US$2,220.16 per patient. Conclusions: The most frequent cause of stroke mimic was TIA, and thrombolysis was performed in 0.9% of cases. The direct costs incurred by activating the stroke code, diagnostic tests, treatment with intravenous thrombolysis, and hospitalization of patients with stroke mimic are lower compared to other studies.